Liquid Biopsy for Precision Oncology Summit 2026

Learn about clinically validated liquid biopsy CGP and MRD solutions developed to support global patient management clinical trials​

Expanding access to CGP: Bridging gaps and facilitating integration to reach more patients​

 Comprehensive Genomic Profiling (CGP) is a cornerstone of precision medicine, yet access remains uneven across patient populations, particularly in underserved areas. This workshop will feature a panel of subject matter experts from across the industry who will share insights on expanding accessibility to CGP testing.  We will explore the real-world barriers that limit access to comprehensive genomic profiling - such as geographic disparities, gaps in infrastructure, and the cost of testing. The session will also highlight emerging solutions such as integration with electronic medical records (EMRs) and adoption of scalable technologies to facilitate integration of this testing practice into routine clinical workflows. Attendees will gain insight into tools and digital strategies that help bridge testing gaps and enable broader, more equitable access to increased genomic insights that may help improve outcomes.​

Driving precision oncology development: Integrated biomarker testing solutions that deliver impact

Biomarker testing is foundational to successful targeted and immunotherapy development. From discovery to commercialization, strategic biomarker integration accelerates research and development, improves patient stratification and reduces trial risk. Robust biomarker strategies can enhance therapy differentiation while streamlining regulatory approval processes and improving ROI in a competitive, precision-driven environment.